Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy
Manuela Berto Pucca, Felipe Augusto Cerni, Isadora Sousa de Oliveira, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 168

Showing 1-25 of 168 citing articles:

Bee Venom: An Updating Review of Its Bioactive Molecules and Its Health Applications
María Carpena, Bernabé Núñez-Estévez, Anton Soria-López, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3360-3360
Open Access | Times Cited: 139
Modern venomics—Current insights, novel methods, and future perspectives in biological and applied animal venom research
Björn M. von Reumont, Gregor Anderluh, Agostinho Antunes, et al.
GigaScience (2022) Vol. 11
Open Access | Times Cited: 70
Natural Sources of Therapeutic Agents Used in Skin Conditions
Monica Dinu, Alin Laurențiu Tatu, Dorin Ioan Cocoș, et al.
Life (2024) Vol. 14, Iss. 4, pp. 492-492
Open Access | Times Cited: 24
Pharmaceutical Prospects of Bee Products: Special Focus on Anticancer, Antibacterial, Antiviral, and Antiparasitic Properties
Firzan Nainu, Ayu Masyita, Muh. Akbar Bahar, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 822-822
Open Access | Times Cited: 101
Bee Venom: From Venom to Drug
Abdelwahab Khalil, Basem H. Elesawy, Tarek M. Ali, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4941-4941
Open Access | Times Cited: 66
Strategies for Improving Transdermal Administration: New Approaches to Controlled Drug Release
Olimpia Dumitriu Buzia, Ana Maria Păduraru, Claudia Simona Ștefan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1183-1183
Open Access | Times Cited: 35
Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review
Kadry M. Sadek, Naira A. Shib, Ehab S. Taher, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Bee Venom Enhances Performance and Immune Function in Thinlip Mullet: A Promising Approach for Sustainable Aquaculture
Mohammed F. El Basuini, Reham Yehia Ibrahim Zalat, Abdelaziz M. El‐Hais, et al.
Fish & Shellfish Immunology (2024) Vol. 151, pp. 109713-109713
Closed Access | Times Cited: 8
Feasibility Study: Varespladib protects rodents from lethal doses of whole bee (Apis mellifera) venom.
James Hearth, Kaitlin Linne, Jerry Harrison, et al.
Toxicon X (2025) Vol. 25, pp. 100214-100214
Open Access | Times Cited: 1
Venoms and Extracellular Vesicles: A New Frontier in Venom Biology
Auwal A. Bala, Naoual Oukkache, Elda E. Sánchez, et al.
Toxins (2025) Vol. 17, Iss. 1, pp. 36-36
Open Access | Times Cited: 1
Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities
Andreas Aufschnaiter, Verena Kohler, Shaden Khalifa, et al.
Toxins (2020) Vol. 12, Iss. 2, pp. 66-66
Open Access | Times Cited: 65
Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
Keneth Iceland Kasozi, Gniewko Niedbała, Mohammed Alqarni, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 53
Bee Venom in Wound Healing
Anna Kurek-Górecka, Katarzyna Komosińska‐Vassev, Anna Rzepecka‐Stojko, et al.
Molecules (2020) Vol. 26, Iss. 1, pp. 148-148
Open Access | Times Cited: 51
Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells
Ghada H. Mansour, Mohammed A. El‐Magd, Dalia H. Mahfouz, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105329-105329
Closed Access | Times Cited: 42
Beehive Products as Antibacterial Agents: A Review
Rita Abou Nader, Rawan Mackieh, Rim Wehbe, et al.
Antibiotics (2021) Vol. 10, Iss. 6, pp. 717-717
Open Access | Times Cited: 41
Pharmacological properties and therapeutic potential of honey bee venom
Amjad Ullah, Fahad M. Aldakheel, Syed Ishtiaq Anjum, et al.
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 1, pp. 96-109
Open Access | Times Cited: 31
Can Bee Venom Be Used as Anticancer Agent in Modern Medicine?
Agata Małek, Maciej Strzemski, Joanna Kurzepa, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3714-3714
Open Access | Times Cited: 21
Chemical Composition and Antimicrobial Properties of Honey Bee Venom
Valery A. Isidorov, Adam Zalewski, Grzegorz Zambrowski, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4135-4135
Open Access | Times Cited: 16
Standardized guidelines for Africanized honeybee venom production needed for development of new apilic antivenom
Ricardo de Oliveira Orsi, Rodrigo Zaluski, Luciana Curtolo de Barros, et al.
Journal of Toxicology and Environmental Health Part B (2024) Vol. 27, Iss. 2, pp. 73-90
Closed Access | Times Cited: 7
The Therapeutic Potential of Bee Venom-Derived Apamin and Mellitin Conjugates in Cancer Treatment: A Systematic Review
Lucas Fornari Laurindo, Enzo Pereira de Lima, Lívia Fornari Laurindo, et al.
Pharmacological Research (2024), pp. 107430-107430
Open Access | Times Cited: 6
Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A2 and Cytotoxins
Manuela Berto Pucca, Shirin Ahmadi, Felipe Augusto Cerni, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 43
Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate Staphylococcus aureus and Staphylococcal Skin Infection
Sirikwan Sangboonruang, Natthawat Semakul, Mohammad A. Obeid, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7639-7661
Open Access | Times Cited: 34
Improving Reproductive Performance and Health of Mammals Using Honeybee Products
Nesrein M. Hashem, Eman M. Hassanein, Jesús Simal‐Gándara
Antioxidants (2021) Vol. 10, Iss. 3, pp. 336-336
Open Access | Times Cited: 33
Fabrication and characterization of bee venom-loaded nanoliposomes: Enhanced anticancer activity against different human cancer cell lines via the modulation of apoptosis-related genes
Alaa Abd El-Gawad, Mohamed Kenawy, Tamer M. El‐Messery, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104545-104545
Closed Access | Times Cited: 15
Evaluating the antibacterial efficacy of bee venom against multidrug-resistant pathogenic bacteria: Escherichia coli, Salmonella typhimurium, and Enterococcus faecalis
Emad H. El-Bilawy, Islam Mamdouh, Said I. Behiry, et al.
World Journal of Microbiology and Biotechnology (2025) Vol. 41, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top